Evogene director Leon Recanati buys 800,000 shares for $400,000
Reuters2026/08/05 20:08- Evogene director Leon Recanati bought 800,000 ordinary shares at a weighted average price of USD 0.5.
- Recanati’s direct holding rose to 883,886 ordinary shares.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
OpenAI enterprise business shows "strong momentum," CFO: 32% month-on-month growth in July
According to media reports, OpenAI CFO Sarah Friar stated that the company's enterprise business has performed "very strongly" recently; OpenAI's overall annualized revenue run rate in July increased by 20% compared to the previous month, with enterprise business up 32% month-on-month, outpacing the growth of personal consumer business.
Adobe names Anil Chakravarthy CEO effective Dec. 1, 2026
Cytokinetics EVP R&D Malik Fady Ibraham disposes of 3,500 common shares for $264,110